z-logo
open-access-imgOpen Access
Recombinant Growth Hormone Therapy in Patients With Ischemic Cardiomyopathy
Author(s) -
Sabine GenthZotz,
Rainer J. Zotz,
Stefanie Geil,
Thomas Voigtländer,
Jürgen Meyer,
Harald Darius
Publication year - 1999
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.99.1.18
Subject(s) - medicine , recombinant dna , cardiomyopathy , cardiology , growth hormone , ischemic cardiomyopathy , human growth hormone , hormone , heart failure , ejection fraction , biochemistry , gene , chemistry
We studied the effects of recombinant growth hormone (rhGH) on exercise capacity and cardiac function in patients with ischemic cardiomyopathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom